Rachel S Sussman, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · Indian Health Center of Santa Clara Valley
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sussman’s office at (408) 995-5453 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133996 · Current
Licensed to practise in California · since 2014 · expires 2026-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$46,050
Medicare paid this office $46,050 for 117 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 56 | $16,479 | $111 |
| Long return visit (40+ min) | 27 | $5,628 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $4,760 | $103 |
| Short return visit (20+ min) | 22 | $3,232 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,909 | $153 |
See all 10 services
| Return visit (30+ min) | 56 | $16,479 | $111 |
| Long return visit (40+ min) | 27 | $5,628 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $4,760 | $103 |
| Short return visit (20+ min) | 22 | $3,232 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,909 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,613 | $154 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 40 | $1,554 | $15 |
| Influenza vaccine split virus, preservative free | 12 | $1,054 | $81 |
| Hospital discharge day management, 30 minutes or less | 14 | $961 | $69 |
| Administration of influenza virus vaccine | 12 | $497 | $38 |
Who their Medicare patients are
117 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 12% · Women 62% · Also on Medicaid 25% · Health risk score 1.46. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 37% · Coronary heart disease 28% · Depression 26% · Chronic kidney disease 24% · Heart failure 20% · COPD 18% · Atrial fibrillation 17% · Stroke 15% · Cancer 11% · Dementia 10%.
The office billed $171,618, Medicare allowed $59,887 and paid $46,050; for 547 services of 32 kinds; $3,179 of it was for drugs given in the office and $42,871 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 117 | 547 | 73 | 1.46 | $171,618 | $46,050 |
| 2023 | 117 | 418 | 73 | 2.16 | $147,342 | $39,753 |
| 2022 | 114 | 358 | 74 | 1.87 | $125,637 | $35,425 |
| 2021 | 110 | 324 | 73 | 2.10 | $129,190 | $34,710 |
| 2020 | 115 | 305 | 73 | 2.07 | $117,013 | $27,676 |
| 2019 | 132 | 430 | 74 | 1.74 | $152,864 | $36,679 |
| 2018 | 139 | 456 | 73 | 2.11 | $156,505 | $41,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 41 | $10,708 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $8,545 | $104 |
| Short return visit (20+ min) | 20 | $4,570 | $73 |
| Long return visit (40+ min) | 17 | $2,727 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,344 | $156 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,871 | $156 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,632 | $71 |
| Influenza vaccine split virus, preservative free | 11 | $791 | $72 |
| Administration of influenza virus vaccine | 12 | $444 | $37 |
2022: 8 services
| Return visit (30+ min) | 40 | $7,998 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,748 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,152 | $181 |
| Short return visit (20+ min) | 23 | $3,967 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,529 | $158 |
| Hospital discharge day management, 30 minutes or less | 15 | $965 | $64 |
| Influenza vaccine split virus, preservative free | 14 | $960 | $69 |
| Administration of influenza virus vaccine | 17 | $633 | $37 |
2021: 5 services
| Return visit (30+ min) | 42 | $9,251 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,975 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,782 | $187 |
| Short return visit (20+ min) | 17 | $2,365 | $84 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,859 | $69 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $7,162 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,964 | $186 |
| Return visit (30+ min) | 36 | $4,490 | $85 |
| Short return visit (20+ min) | 33 | $3,410 | $64 |
2019: 7 services
| Return visit (30+ min) | 52 | $12,295 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,600 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,426 | $181 |
| Short return visit (20+ min) | 32 | $3,532 | $61 |
| Influenza vaccine split virus, preservative free | 15 | $823 | $55 |
| Administration of influenza virus vaccine | 19 | $390 | $21 |
| Administration of pneumococcal vaccine | 15 | $308 | $21 |
2018: 6 services
| Return visit (30+ min) | 39 | $8,566 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,130 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,095 | $182 |
| Short return visit (20+ min) | 33 | $5,342 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,615 | $65 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,841 | $167 |
Medicaid work
$172,893 in 2024
Medicaid paid $172,893 for 1,966 billed services this clinician did in 2024, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 637 | $161,072 |
| Short return visit (20+ min) | 667 | $5,580 |
| Return visit (30+ min) | 337 | $4,725 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 300 | $1,256 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 25 | $261 |
| 2024 | 1,966 | 5 | 78 | $172,893 |
| 2023 | 2,230 | 7 | 78 | $183,327 |
| 2022 | 1,699 | 7 | 87 | $132,481 |
| 2021 | 2,131 | 7 | 80 | $175,829 |
| 2020 | 1,098 | 7 | 63 | $110,393 |
| 2019 | 548 | 3 | 51 | $85,690 |
| 2018 | 312 | 4 | 66 | $50,276 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 745 | $176,345 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 139 | $2,675 |
| Short return visit (20+ min) | 742 | $1,426 |
| Return visit (30+ min) | 359 | $1,217 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 212 | $855 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $625 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $184 |
2022
| Clinic visit/encounter, all-inclusive | 562 | $127,903 |
| Short return visit (20+ min) | 699 | $1,677 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 278 | $1,380 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $882 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $357 |
| Return visit (30+ min) | 81 | $167 |
| Short return visit | 32 | $114 |
2021
| Clinic visit/encounter, all-inclusive | 720 | $169,109 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 179 | $2,268 |
| Short return visit (20+ min) | 785 | $1,532 |
| 1ST HOSP IP/OBS HIGH 75 | 33 | $1,395 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 259 | $1,110 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 24 | $244 |
| Short return visit | 131 | $172 |
2020
| Clinic visit/encounter, all-inclusive | 477 | $107,674 |
| Short return visit (20+ min) | 426 | $950 |
| 1ST HOSP IP/OBS HIGH 75 | 20 | $681 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 68 | $573 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 65 | $300 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 13 | $139 |
| Short return visit | 29 | $77 |
2019
| Clinic visit/encounter, all-inclusive | 375 | $84,863 |
| Short return visit (20+ min) | 161 | $728 |
| Short return visit | 12 | $99 |
2018
| Clinic visit/encounter, all-inclusive | 215 | $47,751 |
| Short return visit (20+ min) | 70 | $1,638 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $653 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $234 |
Drugs they prescribed that Part D paid
$83,132
Pharmacies billed $83,132 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (56 of 819) in 2024. A higher opioid share than 9 in 10 peers; the typical family practice clinician is at 2%. Long-acting opioids: 21% of their opioid prescriptions.
746 generic and fewer than 11 brand-name prescriptions · $83,132 in drug cost · 23 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vivitrol | 14 | $22,536 | $1,610 |
| Buprenorphine-Naloxone | 65 | $9,266 | $143 |
| Buprenorphine | 11 | $1,183 | $108 |
| Hydrocodone-Acetaminophen | 33 | $659 | $20 |
| Gabapentin | 37 | $536 | $14 |
See all 18 drugs
| Vivitrol | 14 | $22,536 | $1,610 |
| Buprenorphine-Naloxone | 65 | $9,266 | $143 |
| Buprenorphine | 11 | $1,183 | $108 |
| Hydrocodone-Acetaminophen | 33 | $659 | $20 |
| Gabapentin | 37 | $536 | $14 |
| Atorvastatin | 70 | $417 | $6 |
| Losartan | 31 | $230 | $7 |
| Cyclobenzaprine | 20 | $223 | $11 |
| Clonazepam | 15 | $206 | $14 |
| Escitalopram | 15 | $178 | $12 |
| Trazodone | 19 | $156 | $8 |
| Metoprolol | 11 | $136 | $12 |
| Diazepam | 25 | $131 | $5 |
| Metformin | 12 | $89 | $7 |
| Lisinopril | 13 | $76 | $6 |
| Amlodipine Besylate | 28 | $70 | $3 |
| Chlordiazepoxide | 13 | $61 | $5 |
| Lorazepam | 11 | $38 | $3 |
Year by year
| 2024 | 819 | 135 | 7% (56) | None | $83,132 |
| 2023 | 810 | 135 | 4% (30) | None | $106,722 |
| 2022 | 719 | 107 | 4% (27) | None | $73,823 |
| 2021 | 713 | 128 | 8% (54) | None | $48,507 |
| 2020 | 715 | 139 | 6% (42) | None | $49,716 |
| 2019 | 768 | 130 | 6% (43) | None | $62,201 |
| 2018 | 619 | 107 | 4% (25) | None | $58,894 |
| 2017 | 160 | 54 | None | 19% | $13,161 |
| 2016 | 307 | 42 | None | None | $10,426 |
| 2015 | 301 | 58 | 6% (17) | None | $40,873 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Ozempic | 17 | $36,392 | $2,141 |
| Buprenorphine-Naloxone | 55 | $11,647 | $212 |
| Buprenorphine | 12 | $4,391 | $366 |
| Naltrexone | 16 | $1,327 | $83 |
| Mirtazapine | 21 | $1,325 | $63 |
| Atorvastatin | 61 | $876 | $14 |
| Gabapentin | 32 | $384 | $12 |
| Losartan | 38 | $336 | $9 |
| Metoprolol | 14 | $288 | $21 |
| Rosuvastatin | 14 | $287 | $21 |
| Bupropion Xl | 15 | $272 | $18 |
| Amlodipine Besylate | 30 | $260 | $9 |
| Trazodone | 14 | $229 | $16 |
| Metformin | 16 | $173 | $11 |
| Lisinopril | 21 | $170 | $8 |
| Pantoprazole | 13 | $164 | $13 |
| Cyclobenzaprine | 17 | $160 | $9 |
| Escitalopram | 12 | $138 | $11 |
| Diazepam | 14 | $94 | $7 |
2022: 13 drugs
| Buprenorphine-Naloxone | 65 | $10,663 | $164 |
| Buprenorphine | 14 | $4,519 | $323 |
| Atorvastatin | 55 | $638 | $12 |
| Gabapentin | 31 | $592 | $19 |
| Rosuvastatin | 12 | $498 | $41 |
| Pantoprazole | 20 | $261 | $13 |
| Trazodone | 12 | $223 | $19 |
| Losartan | 26 | $196 | $8 |
| Metformin | 16 | $139 | $9 |
| Amlodipine Besylate | 24 | $131 | $5 |
| Lisinopril | 25 | $118 | $5 |
| Cyclobenzaprine | 15 | $117 | $8 |
| Simvastatin | 16 | $103 | $6 |
2021: 20 drugs
| Buprenorphine-Naloxone | 69 | $7,501 | $109 |
| Buprenorphine | 13 | $4,990 | $384 |
| Naltrexone | 11 | $1,233 | $112 |
| Atorvastatin | 47 | $789 | $17 |
| Gabapentin | 26 | $422 | $16 |
| Escitalopram | 14 | $366 | $26 |
| Rosuvastatin | 11 | $307 | $28 |
| Losartan | 24 | $241 | $10 |
| Hydrocodone-Acetaminophen | 17 | $233 | $14 |
| Metformin | 12 | $214 | $18 |
| Pantoprazole | 12 | $206 | $17 |
| Lisinopril | 30 | $153 | $5 |
| Amlodipine Besylate | 23 | $149 | $6 |
| Citalopram Hbr | 12 | $105 | $9 |
| Furosemide | 11 | $96 | $9 |
| Trazodone | 13 | $85 | $7 |
| Levothyroxine | 11 | $84 | $8 |
| Simvastatin | 12 | $81 | $7 |
| Cyclobenzaprine | 11 | $76 | $7 |
| Naproxen | 13 | $38 | $3 |
2020: 16 drugs
| Buprenorphine-Naloxone | 34 | $3,900 | $115 |
| Atorvastatin | 57 | $898 | $16 |
| Hydrocodone-Acetaminophen | 16 | $452 | $28 |
| Amlodipine Besylate | 36 | $312 | $9 |
| Chlorthalidone | 11 | $296 | $27 |
| Gabapentin | 21 | $294 | $14 |
| Tamsulosin | 16 | $291 | $18 |
| Metformin | 15 | $259 | $17 |
| Pravastatin | 11 | $209 | $19 |
| Losartan | 16 | $193 | $12 |
| Lisinopril | 38 | $182 | $5 |
| Simvastatin | 13 | $138 | $11 |
| Atenolol | 14 | $110 | $8 |
| Citalopram Hbr | 21 | $107 | $5 |
| Escitalopram | 11 | $89 | $8 |
| Furosemide | 15 | $65 | $4 |
2019: 20 drugs
| Buprenorphine-Naloxone | 32 | $2,986 | $93 |
| Bupropion Xl | 12 | $832 | $69 |
| Buprenorphine | 19 | $700 | $37 |
| Mirtazapine | 12 | $621 | $52 |
| Atorvastatin | 34 | $544 | $16 |
| Naltrexone | 13 | $489 | $38 |
| Pravastatin | 18 | $470 | $26 |
| Levothyroxine | 13 | $346 | $27 |
| Tamsulosin | 19 | $338 | $18 |
| Hydrocodone-Acetaminophen | 18 | $300 | $17 |
| Lisinopril | 43 | $295 | $7 |
| Gabapentin | 14 | $254 | $18 |
| Escitalopram | 11 | $203 | $18 |
| Amlodipine Besylate | 29 | $175 | $6 |
| Simvastatin | 12 | $155 | $13 |
| Metformin | 15 | $148 | $10 |
| Atenolol | 17 | $140 | $8 |
| Losartan | 14 | $110 | $8 |
| Citalopram Hbr | 14 | $88 | $6 |
| Trazodone | 13 | $83 | $6 |
2018: 14 drugs
| Buprenorphine-Naloxone | 15 | $1,257 | $84 |
| Levothyroxine | 25 | $467 | $19 |
| Pravastatin | 22 | $403 | $18 |
| Atorvastatin | 35 | $297 | $8 |
| Buprenorphine | 21 | $278 | $13 |
| Gabapentin | 19 | $273 | $14 |
| Nortriptyline | 13 | $219 | $17 |
| Tamsulosin | 11 | $212 | $19 |
| Lisinopril | 28 | $151 | $5 |
| Metformin | 26 | $127 | $5 |
| Citalopram Hbr | 18 | $124 | $7 |
| Amlodipine Besylate | 15 | $113 | $8 |
| Prednisone | 13 | $93 | $7 |
| Furosemide | 12 | $75 | $6 |
2017: 5 drugs
| Buprenorphine-Naloxone | 44 | $4,480 | $102 |
| Suboxone | 12 | $4,224 | $352 |
| Narcan | 12 | $1,505 | $125 |
| Atorvastatin | 11 | $72 | $7 |
| Losartan | 12 | $66 | $5 |
2016: 9 drugs
| Losartan | 23 | $224 | $10 |
| Simvastatin | 13 | $202 | $16 |
| Atorvastatin | 12 | $132 | $11 |
| Metformin | 12 | $129 | $11 |
| Trazodone | 15 | $112 | $7 |
| Lisinopril | 13 | $94 | $7 |
| Bupropion Xl | 13 | $88 | $7 |
| Alendronate | 11 | $66 | $6 |
| Sertraline | 12 | $53 | $4 |
2015: 6 drugs
| Hydrocodone-Acetaminophen | 14 | $257 | $18 |
| Amitriptyline | 11 | $181 | $16 |
| Metformin | 13 | $175 | $13 |
| Levothyroxine | 11 | $173 | $16 |
| Furosemide | 14 | $79 | $6 |
| Trazodone | 13 | $49 | $4 |
Professional record
- NPI
- 1184064396
- Licence
- CA A133996California A133996: Current · expires 2026-09-30
- Trained
- Stanford University School of Medicine, 2013
- Group
- University Healthcare Alliance · Indian Health Center of Santa Clara Valley
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Federal specialty code 207RA0401X (207RA0401X); Student in a training program (390200000X)
- Mailing address
- 455 Oconnor Dr Ste 210, San Jose, CA, 95128
- NPI first listed
- 2013-07-02
- NPI last updated
- 2023-04-10
- NPI record certified
- 2023-04-10
This is when the NPI record was last certified, not a medical board exam.